More Closed Doors for August Science Grant Evaluations
Published Date: 7/10/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings on August 12, 2025, to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide which projects get funding. Scientists and researchers applying for grants will be affected, with no direct cost changes but key decisions happening on that day.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH grant and contract reviews Aug 12–15, 2025
On August 12–15, 2025, the NIH Center for Scientific Review will hold closed virtual meetings to review and evaluate grant applications and contract proposals. Panels listed include reviews such as Catalyze: Enabling Technologies and Product Definition (Aug 12), RFA-AI-24-068: New Therapeutic Strategies for Genital Herpes (Aug 12), Cellular and Molecular Biology of Complex Brain Disorders (Aug 13–14), and others; these meetings will decide which projects receive funding.
Meetings closed to protect confidential material
The meetings are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (including patentable material), and personal information about individuals associated with applications. This protects applicants’ proprietary information and privacy during the review and evaluation process.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2025-12790, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in August 2025 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for health research. Scientists and research groups applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or new costs.
Next: 2025-12792, Certain Human Milk Oligosaccharides and Methods of Producing the Same; Notice of Commission Decision To Institute a Rescission Proceeding and To Rescind the Limited Exclusion Order; Termination of the Rescission Proceeding
The U.S. International Trade Commission decided to cancel a special order that was blocking certain human milk sugar products from coming into the U.S. This affects companies like Glycosyn LLC and Chr. Hansen HMO GmbH, ending restrictions on these products. The change means these products can now be imported and sold freely, with no new fees or penalties starting immediately.